Clayton, MO, United States of America

Stephen M Beverley

USPTO Granted Patents = 10 



Average Co-Inventor Count = 2.2

ph-index = 6

Forward Citations = 215(Granted Patents)


Company Filing History:


Years Active: 2008-2019

Loading Chart...
Loading Chart...
Loading Chart...
10 patents (USPTO):Explore Patents

Title: The Innovations of Inventor Stephen M Beverley

Introduction:

Stephen M Beverley, a talented inventor based in Clayton, MO (US), has made significant contributions to the field of targeted therapeutic proteins. With a total of 10 patents to his name, Beverley's innovative approach to developing therapeutics has garnered attention in the scientific community.

Latest Patents:

His most recent patents focus on targeted therapeutic proteins that localize to specific subcellular compartments such as the lysosome. These targeted therapeutics consist of a therapeutic agent and a targeting moiety that binds to a receptor on the cell's exterior surface. This unique design allows for proper subcellular localization of the therapeutic upon receptor internalization, offering promising treatment options for various medical conditions. Nucleic acids, cells, and methods related to this invention are also included, showcasing Beverley's comprehensive approach to medical innovation.

Career Highlights:

Beverley has an impressive background working with renowned companies in the pharmaceutical industry. Some of the notable companies he has been associated with include Biomarin Pharmaceutical Inc. and Zystor Therapeutics, Inc. These experiences have undoubtedly shaped his innovative thinking and fueled his passion for developing groundbreaking medical solutions.

Collaborations:

Throughout his career, Beverley has collaborated with accomplished professionals in the field. Noteworthy individuals like Jonathan LeBowitz and William S Sly have been his coworkers, reflecting Beverley's commitment to teamwork and knowledge sharing in the pursuit of scientific advancements.

Conclusion:

Inventor Stephen M Beverley's work in the realm of targeted therapeutic proteins exemplifies his dedication to pushing the boundaries of medical innovation. With a strong track record of patents and collaborations with industry experts, Beverley continues to make a lasting impact on the field of biopharmaceuticals. His inventive spirit and commitment to excellence position him as a key figure in shaping the future of targeted therapeutics.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…